Navigation Links
A prognosis for GE and Abbott Diagnostics

What is more important: diagnostics, therapeutics, or prognosis? While all are important, we will in this column see how past history has addressed this question and also how recent events, such as GE's acquisition of Abbott's diagnostics units, shed light on this fundamental issue.

It is al......

Full article >>> t centers.

While his emphasis on treatment facilities was simply an oversight, a radiologist friend of mine couldn't help but cheekily point out whether it meant that diagnostic centers were to be left as open targets. While we were not often in a joking mood during those days, it did point out how deeply ingrained our focus on treatment has become.

While diagnosis plays second f......

Full article >>> such as its pharmaceuticals and devices - are marketed mostly through physicians and direct-to-consumer channels.

GE has a significant marketing advantage and experience when it comes to big-box purchases. Moreover, the GE commercial finance arm also facilitates the ability to purchase these big boxes through leasing or other arrangements. The same marketing strength can also be applied t......

Full article >>> t means that radiologic diagnoses can be done at the bedside with a portable scanner, in the CT/MRI suite or in the ER, as opposed to getting your results later that evening. If you can do that with a huge, multimillion-dollar MRI machine, why can't you do that with a simple blood test?

Indeed, that is the premise behind Abbott's point-of-care system. This is how the cultural paradigm tha......

Full article >>> ts.jsp?release_id=12212">press release does not usually count as high-end literary criticism, reading more deeply reveals some important messages.

In this regard, Abbott may be considering its in-vitro and point-of-care businesses as commodities compared to its molecular business. Without the infusion of GE's hospital-based marketing focus, GE's advanced radiologic technology and GE's......

Full article >>> live, and how well they will live. To answer the question posed at the beginning of this column, most people will agree that in this context, prognosis ranks first.

Abbott is betting on the supremacy of prognosis. While the GE acquisition makes excellent business sense for GE, the future lies with those companies that can accurately, relevantly, and usefully bring prognostic information ......

Full article >>> . He can be e-mailed at ogan@midwestbusiness.com.

This article previously appeared in MidwestBusiness.com, and was reprinted with its permission.

The opinions expressed herein or statements made in the above column are solely those of the author, and do not necessarily reflect the views of ......

Full article >>>
'"/>

Source:wistechnology.com By Ogan Gurel 02/05/07


Related biology technology :

1. Abbott vs. Thailand has implications for innovation and access
2. Wisconsin court halts Abbotts sale of genotyping products
3. Wisconsin court affirms damages in Innogenetics, Abbott patent case
4. Abbott Labs campus in Kenosha could send ripples through local biotech
5. Abbott Executive Jim Tyree Takes IBIO Helm
6. Promega Announces Agreement with Abbott
7. Roche Diagnostics Corporation
8. Roche Diagnostics Corporation
9. BioDiagnostics is first seed-testing lab to gain new accreditation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... ... on what they believe could be a new and helpful biomarker for malignant ... Click here to read it now. , Biomarkers are components in ...
(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016   The Weather Company , an IBM ... an industry-first capability in which consumers will be able to ... ask questions via voice or text and receive relevant information ... Marketers have long sought an advertising solution that ... be personal, relevant and valuable; and can scale across millions ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
Breaking Biology News(10 mins):